
Aemetis (AMTX) Stock Forecast & Price Target
Aemetis (AMTX) Analyst Ratings
Bulls say
Aemetis Inc., a renewable fuel and biochemicals company, is projected to experience significant revenue growth, with an expected increase from $398 million in 2025 to $1.8 billion by 2036, reflecting a robust eleven-year compound annual growth rate (CAGR) of approximately 14.4%. The company's operations are bolstered by solid execution and an upcoming rebound in its India segment, along with the potential for improved cash flows from its renewable natural gas business and an IPO of its biodiesel operations in 2025, which could enhance its balance sheet. Additionally, while operating expenses are anticipated to rise at a CAGR of 8.9%, the overall outlook for Aemetis remains positive, suggesting substantial upside potential from the current share price.
Bears say
Aemetis Inc. experienced a significant decline in revenue from its India operations, with Q4 revenues dropping to $3 million from $32 million in Q3 2024. The company's net loss for fiscal Q4 2024 stood at $16.2 million, translating to a loss of $0.36 per share, although this was an improvement compared to a net loss of $25.4 million and a loss of $0.64 per share in the previous year’s fourth quarter. Additionally, the reported EPS of $(0.36) was slightly better than the estimated $(0.32), yet still fell within a disappointing range relative to market expectations of $(0.41).
This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.
Aemetis (AMTX) Analyst Forecast & Price Prediction
Start investing in Aemetis (AMTX)
Order type
Buy in
Order amount
Est. shares
0 shares